IRIS

Chloroform

CASRN 67-66-3 | DTXSID1020306

IRIS Toxicological Review of Chloroform (Final Report, 2001)

On this page:

Notice - This site contains archived material(s)

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact us form if you need additional support.


Overview

EPA is announcing the release of the final report, Toxicological Review of Chloroform: in support of the Integrated Risk Information System (IRIS). The updated Summary for Chloroform and accompanying final report have also been added to the IRIS Database.

Citation

U.S. EPA. IRIS Toxicological Review of Chloroform (Final Report, 2001). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-01/001, 2001.

Top of Page


Background

Chloroform (trichloromethane) is a colorless, volatile liquid with a distinct odor. Chloroform is nonflammable. It is slightly soluble in water and is readily miscible with most organic solvents. Because chloroform is relatively volatile, it tends to escape from contaminated environmental media (e.g., water or soil) into air, and may also be released in vapor form from some types of industrial or chemical operations. Therefore, humans may be exposed to chloroform not only by ingestion of chloroform in drinking water, food, or soil, but also by dermal contact with contaminated media (especially water) and by inhalation of vapor (especially in indoor air).

History/Chronology

Date Description
01- Sep 1984 EPA released the Health Effects Assessment for Chloroform.
02- Apr 1988 EPA released the Updated Health Effects Assessment for Chloroform.
03- Oct 2001 EPA released the final tox report and summary document and posted these to the IRIS database.

Top of Page

Download(s)

This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.

Top of Page

Quick Check

Quick check is a visual indication of the current step that this IRIS assessment has started or is in.